Strategic Advocacy
The Strategic Advocacy division is comprised of several major policy divisions within the Chamber including theCyber, Space, and National Security Division; Economic Policy Division; Employment Policy Division; and Small Business Policy Division. Environmental Affairs and Sustainability, Health Policy, and Transportation and Infrastructure Policy are also under the umbrella of the Policy Group.
The division works closely with the Chamber's Congressional and Public Affairs and Political Affairs and Federation Relations divisions.
Latest Content
VP Pence and more.
On Friday, May 19, the Chamber, along with 7 other trade associations representing insurers, hospitals, physicians and employers, sent a letter to U.S. Department of Health and Human Services Secretary Tom Price. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
On Friday, May 19, the Chamber, along with 7 additional trade associations representing insurers, hospitals, physicians and employers, sent a letter to Office of Management and Budget Director Mick Mulvaney. The letter outlines serious concerns about the continued uncertainty around funding for cost-sharing reduction (CSR) payments and the negative impacts uncertainty will have on millions of Americans if it is not addressed.
VIA ELECTRONIC FILING TO: James BelkeU.S. Environmental Protection AgencyOffice of Land and Emergency Management1200 Pennsylvania Ave NWMail Code 5104AWashington, DC 20460 RE: Comments on Accidental Release Prevention Requirements: Risk Management Programs Under the Clean Air Act; Further Delay of Effective Date (82 Fed. Reg. 16146) (April 3, 2017) Docket No. EPA-HQ-OEM-2015-0725; RIN 2050-AG91 Dear Mr. Belke:
A recent Detroit Free Press report about the dismissal of several individuals who skipped work to attend a political protest highlighted...
This letter was sent to Chairman Brady and the members of the Committee on Ways and Means expressing the Chamber’s commitment to comprehensive tax reform.
This letter was sent to the members of the House Subcommittee on Health opposing any amendments that may be offered to the Food and Drug Administration Reauthorization Act of 2017 that would allow the importation of foreign pharmaceuticals into the United States or that would undermine the preemptive authority of federal food and drug regulations. The Subcommittee is marking up the bill tomorrow morning. May 17, 2017
On May 2nd, Senators Corey Booker (D- NJ) and Sherrod Brown (D- Ohio) sent letters to 10 airline CEOs...
